Proficio Capital Partners’s Haemonetics HAE Stock Holding History

Proficio Capital Partners’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-46	Closed	-$6K	–	721
2019 Q2	$6K	Buy	46 +36	+360%	+$3.54K	﹤0.01%	1137
2019 Q1	$1K	Buy	+10	New	+$909	﹤0.01%	1524
2018 Q4	–	Sell	-8	Closed	-$1K	–	1213
2018 Q3	$1K	Sell	8 -4	-33%	-$414	﹤0.01%	1159
2018 Q2	$1K	Hold	12	–	–	﹤0.01%	1192
2018 Q1	$1K	Hold	12	–	–	﹤0.01%	1195
2017 Q4	$1K	Sell	12 -18	-60%	-$948	﹤0.01%	1178
2017 Q3	$1K	Sell	30 -6	-17%	-$249	﹤0.01%	1169
2017 Q2	$1K	Hold	36	–	–	﹤0.01%	1173
2017 Q1	$1K	Buy	36 +2	+6%	+$78	﹤0.01%	1212
2016 Q4	$1K	Buy	34 +1	+3%	+$38	﹤0.01%	1013
2016 Q3	$1K	Buy	+33	New	+$1.13K	﹤0.01%	963

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Proficio Capital Partners's HAE Position: Q3 2019 in Review

Proficio Capital Partners sold out of Haemonetics (HAE) in Q3 2019, closing a stake of 46 shares — an estimated $6K sold.

Proficio Capital Partners first reported a position in HAE in Q3 2016 and held it in 11 quarters. The position peaked at $6K in Q2 2019. 275 funds tracked by Wall St. Rank hold HAE as of Q3 2019.

Proficio Capital Partners reported no remaining Haemonetics position as of Q3 2019 after selling out during the quarter.
Proficio Capital Partners sold 46 Haemonetics shares in Q3 2019, an estimated $6K.
Proficio Capital Partners first reported a position in Haemonetics in Q3 2016 and held it in 11 quarters.
Proficio Capital Partners's Haemonetics position peaked at $6K in Q2 2019.
275 funds tracked by Wall St. Rank held Haemonetics as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.